not quite what i expected, but still plenty good. the film doesn’t really find its momentum until about halfway through and that had me worried for a while. once it gets over the hill of building characters and plot and setting up the dynamics for the second half, it starts to shine.
i thought it was going to be a film about the dirty side of the pharmaceutical business, but it turned out to be more of a straight thriller and almost more about the mental health business than big pharma. solid film overall. hopefully it’s not soderbergh’s swan song as has been reported.Watched in theater